Skip to main content

Drug Interactions between Opdivo and talimogene laherparepvec

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

nivolumab talimogene laherparepvec

Applies to: Opdivo (nivolumab) and talimogene laherparepvec

If you are currently being treated or are going to begin treatment with nivolumab, you should let your doctor know before receiving talimogene laherparepvec. You may be at risk for developing an infection from talimogene laherparepvec or have a reduced response to talimogene laherparepvec, although this has not been studied. If you have recently received talimogene laherparepvec, your doctor may choose to postpone treatment with nivolumab for a few weeks, or you may need to wait for a period of time after completing your treatment with nivolumab before receiving talimogene laherparepvec. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer